Mehtap Çakır

1.3k total citations
34 papers, 633 citations indexed

About

Mehtap Çakır is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Mehtap Çakır has authored 34 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Mehtap Çakır's work include Thyroid Cancer Diagnosis and Treatment (8 papers), Thyroid Disorders and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Mehtap Çakır is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (8 papers), Thyroid Disorders and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Mehtap Çakır collaborates with scholars based in Türkiye, United Kingdom and United States. Mehtap Çakır's co-authors include Ashley Grossman, Mustafa Kemal Balcı, Nilüfer Balcı, Nehir Samancı, Dorota Dworakowska, Ümit Karayalçın, Hasan Altunbaş, Cumhur Arıcı, Ramazan Sarı and Gülten Karpuzoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology.

In The Last Decade

Mehtap Çakır

33 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehtap Çakır Türkiye 14 278 168 155 141 126 34 633
Paolo Dalino Ciaramella Italy 11 270 1.0× 143 0.9× 211 1.4× 72 0.5× 81 0.6× 21 527
Marianne S. Elston New Zealand 18 505 1.8× 146 0.9× 322 2.1× 213 1.5× 134 1.1× 59 972
Szabolcs Szakáll Hungary 14 125 0.4× 134 0.8× 135 0.9× 94 0.7× 90 0.7× 35 518
Christian Nasr United States 18 560 2.0× 110 0.7× 176 1.1× 91 0.6× 73 0.6× 55 767
Mara Boschetti Italy 18 487 1.8× 276 1.6× 143 0.9× 116 0.8× 153 1.2× 56 884
R. Gasser Austria 23 450 1.6× 230 1.4× 477 3.1× 158 1.1× 245 1.9× 57 1.2k
Alexander L. Shifrin United States 12 271 1.0× 96 0.6× 252 1.6× 84 0.6× 98 0.8× 23 767
I Bachelot France 12 319 1.1× 93 0.6× 152 1.0× 92 0.7× 45 0.4× 19 525
Yoriko Murata Japan 13 136 0.5× 156 0.9× 64 0.4× 64 0.5× 75 0.6× 44 646
Anja Lisbeth Frederiksen Denmark 14 199 0.7× 125 0.7× 81 0.5× 233 1.7× 82 0.7× 46 552

Countries citing papers authored by Mehtap Çakır

Since Specialization
Citations

This map shows the geographic impact of Mehtap Çakır's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehtap Çakır with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehtap Çakır more than expected).

Fields of papers citing papers by Mehtap Çakır

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehtap Çakır. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehtap Çakır. The network helps show where Mehtap Çakır may publish in the future.

Co-authorship network of co-authors of Mehtap Çakır

This figure shows the co-authorship network connecting the top 25 collaborators of Mehtap Çakır. A scholar is included among the top collaborators of Mehtap Çakır based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehtap Çakır. Mehtap Çakır is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çakır, Mehtap, et al.. (2021). COVID-19 HASTALARINDA KORTİKOSTEROİD TEDAVİSİ: NE ZAMAN VE NASIL?. SHILAP Revista de lepidopterología. 28(COVİD-19 ÖZEL SAYI). 197–208.
2.
Çakır, Mehtap & Ashley Grossman. (2018). The Diagnosis of Neuroendocrine Tumours: An Endocrine Perspective. Endocrinology research and practice.. 22(2). 117–144. 1 indexed citations
3.
Çakır, Mehtap, et al.. (2015). The Effect of Hypothyroidism on Color Contrast Sensitivity: A Prospective Study. European Thyroid Journal. 4(1). 43–47. 14 indexed citations
4.
Keskin, Mustafa, et al.. (2012). The Problems and Cost-Effectiveness Analysis of Diabetic Foot Infections. SHILAP Revista de lepidopterología. 3 indexed citations
5.
Esen, Hasan, et al.. (2012). Thyroid Lipomatosis. Internal Medicine. 51(24). 3383–3385. 8 indexed citations
6.
İpekçi, Süleyman Hilmi, Kayhan Öztürk, & Mehtap Çakır. (2011). A Difficult Decision–Hashimoto’s Thyroiditis or Subacute Thyroiditis?. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Çakır, Mehtap. (2011). Water and Salt Metabolism Disorders Following Transsphenoidal Pituitary Surgery. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Çakır, Mehtap & Ashley Grossman. (2011). The molecular pathogenesis and management of bronchial carcinoids. Expert Opinion on Therapeutic Targets. 15(4). 457–491. 13 indexed citations
9.
Çakır, Mehtap, Dorota Dworakowska, & Ashley Grossman. (2010). Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2 – clinical implications. Journal of Cellular and Molecular Medicine. 14(11). 2585–2591. 24 indexed citations
10.
Çakır, Mehtap, Dorota Dworakowska, & Ashley Grossman. (2010). Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 – molecular pathways. Journal of Cellular and Molecular Medicine. 14(11). 2570–2584. 66 indexed citations
11.
Çakır, Mehtap & Ashley Grossman. (2009). Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies. Neuroendocrinology. 90(4). 323–348. 36 indexed citations
12.
Çakır, Mehtap, Mustafa Sait Gönen, Oğuz Dikbaş, & Banu Öztürk. (2009). Thyroid Hemiagenesis with Graves' Disease, Graves' Ophthalmopathy and Multinodular Goiter. Internal Medicine. 48(12). 1047–1049. 10 indexed citations
13.
Çakır, Mehtap, Ramazan Sarı, Özgür Tosun, & Ümit Karayalçın. (2005). Cortisol Levels During an Oral Glucose Tolerance Test in Lean and Obese Women. Endocrine Research. 31(3). 213–218. 10 indexed citations
14.
Erdoğan, Murat Faik, Alptekin Gürsoy, Gökhan Özgen, et al.. (2005). Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study. Journal of Endocrinological Investigation. 28(11). 806–809. 12 indexed citations
15.
Çakır, Mehtap, et al.. (2005). A case of rhabdomyolysis associated with thyrotoxicosis.. PubMed. 97(5). 732–4. 9 indexed citations
16.
Sarı, Ramazan, Mustafa Kemal Balcı, Mehtap Çakır, Hasan Altunbaş, & Ümit Karayalçın. (2004). Comparison of Efficacy of Sibutramine or Orlistat Versus Their Combination in Obese Women. Endocrine Research. 30(2). 159–167. 34 indexed citations
17.
Arıcı, Cumhur, et al.. (2003). Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas. Apmis. 111(3). 439–443. 34 indexed citations
18.
Çakır, Mehtap, Hasan Altunbaş, Mustafa Kemal Balcı, Ümit Karayalçın, & Gülten Karpuzoğlu. (2002). Medullary Thyroid Carcinoma, Follicular Variant. Endocrine Pathology. 13(1). 75–80. 9 indexed citations
19.
Üstün, Celalettin, Muhıt Özcan, Günhan Gürman, et al.. (1999). Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft verses host disease. Pathology & Oncology Research. 5(3). 229–232. 1 indexed citations
20.
Arıcan, Ali, Fikri İçlı, Hakan Akbulut, et al.. (1999). The effect of two different doses of oral clodronate on pain in patients with bone metastases. Medical Oncology. 16(3). 204–210. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Dalino Ciaramella Breakdown of academic impact, for papers by Marianne S. Elston Breakdown of academic impact, for papers by Szabolcs Szakáll Breakdown of academic impact, for papers by Christian Nasr Breakdown of academic impact, for papers by Mara Boschetti Breakdown of academic impact, for papers by R. Gasser Breakdown of academic impact, for papers by Alexander L. Shifrin Breakdown of academic impact, for papers by I Bachelot Breakdown of academic impact, for papers by Yoriko Murata Breakdown of academic impact, for papers by Anja Lisbeth Frederiksen
Rankless by CCL
2026